Literature DB >> 15930117

Distinct roles for Mind bomb, Neuralized and Epsin in mediating DSL endocytosis and signaling in Drosophila.

Weidong Wang1, Gary Struhl.   

Abstract

Ligands of the Delta/Serrate/Lag2 (DSL) family must normally be endocytosed in signal-sending cells to activate Notch in signal-receiving cells. DSL internalization and signaling are promoted in zebrafish and Drosophila, respectively, by the ubiquitin ligases Mind bomb (Mib) and Neuralized (Neur). DSL signaling activity also depends on Epsin, a conserved endocytic adaptor thought to target mono-ubiquitinated membrane proteins for internalization. Here, we present evidence that the Drosophila ortholog of Mib (Dmib) is required for ubiquitination and signaling activity of DSL ligands in cells that normally do not express Neur, and can be functionally replaced by ectopically expressed Neur. Furthermore, we show that both Dmib and Epsin are required in these cells for some of the endocytic events that internalize DSL ligands, and that the two Drosophila DSL ligands Delta and Serrate differ in their utilization of these Dmib- and Epsin-dependent pathways: most Serrate is endocytosed via the actions of Dmib and Epsin, whereas most Delta enters by other pathways. Nevertheless, only those Serrate and Delta proteins that are internalized via the action of Dmib and Epsin can signal. These results support and extend our previous proposal that mono-ubiquitination of DSL ligands allows them to gain access to a select, Epsin-dependent, endocytic pathway that they must normally enter to activate Notch.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930117     DOI: 10.1242/dev.01860

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  85 in total

1.  Interaction between Notch and Hif-alpha in development and survival of Drosophila blood cells.

Authors:  Tina Mukherjee; William Sang Kim; Lolitika Mandal; Utpal Banerjee
Journal:  Science       Date:  2011-06-03       Impact factor: 47.728

Review 2.  Canonical and non-canonical Notch ligands.

Authors:  Brendan D'Souza; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

Review 3.  Notch ligand endocytosis: mechanistic basis of signaling activity.

Authors:  Abdiwahab A Musse; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Semin Cell Dev Biol       Date:  2012-01-24       Impact factor: 7.727

Review 4.  Why is delta endocytosis required for effective activation of notch?

Authors:  Ajay Chitnis
Journal:  Dev Dyn       Date:  2006-04       Impact factor: 3.780

5.  Cell fate-specific regulation of EGF receptor trafficking during Caenorhabditis elegans vulval development.

Authors:  Attila Stetak; Erika Fröhli Hoier; Assunta Croce; Giuseppe Cassata; Pier Paolo Di Fiore; Alex Hajnal
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

6.  Structure-function analysis of delta trafficking, receptor binding and signaling in Drosophila.

Authors:  Annette L Parks; Jane R Stout; Scott B Shepard; Kristin M Klueg; Ana A Dos Santos; Todd R Parody; Martina Vaskova; Marc A T Muskavitch
Journal:  Genetics       Date:  2006-10-08       Impact factor: 4.562

7.  The NHR1 domain of Neuralized binds Delta and mediates Delta trafficking and Notch signaling.

Authors:  Cosimo Commisso; Gabrielle L Boulianne
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

Review 8.  Notch signaling at a glance.

Authors:  Kazuya Hori; Anindya Sen; Spyros Artavanis-Tsakonas
Journal:  J Cell Sci       Date:  2013-05-31       Impact factor: 5.285

9.  Insight into Notch Signaling Steps That Involve pecanex from Dominant-Modifier Screens in Drosophila.

Authors:  Tomoko Yamakawa; Yu Atsumi; Shiori Kubo; Ami Yamagishi; Izumi Morita; Kenji Matsuno
Journal:  Genetics       Date:  2018-05-31       Impact factor: 4.562

Review 10.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.